Research funding

Terra Sigillata

Category archives for Research funding

Unlike the blogosphere and some unhinged stakeholders, I’ve been quietly watching the PZ Myers crackergate episode unfold. My concerns have been less theological than educational, primarily because I am the beneficiary of an arm of the University of Florida public higher education system. I’ve been beating my head against the wall as to why the…

As promised awhile back, my blogging frequency has dropped off a bit as I tend to some more time-consuming details in my meatspace existence. I’ve also missed some fabulous posts around the blogosphere. I wanted to direct Terra Sig readers to a moving yet data-driven essay by Professor PZ Myers at the University of Minnesota…

This one’s for the molecular and cell biology and pharmaceutical chemistry crowd: what’s on your current wishlist? If you had a US$250,000 equipment budget, what would you buy to outfit the lab? Assume that your department has all the big ticket items like real-time PCR, confocal microscopy, flow cytometer, histology gadgetry, >500MHz NMR, MALDI-TOF, LCs,…

Our quick post yesterday cited Jonathan Alter’s Newsweek essay this week on the sad state of cancer research funding in the context of Hamilton Jordan’s recent death and Ted Kennedy’s recent glioblastoma diagnosis. Like many areas of US federal research funding, cancer research support has been flat under the Bush administration and, in fact, declined…

Effective science communication and science advocacy in the public arena has been much discussed in the science blogosphere. But is ranting on science and medical blogs the most effective way to promote science, especially in the United States? I’ve had some discussions with other scientists, including blog colleague PhysioProf, who submit that the best way…

Alison McCook has a lengthy article now up on The Scientist website that illustrates how NIH grant funding shortfalls are coming home to roost, with soft money faculty first to be jettisoned. In 2007, more than 4,000 NIH-funded researchers were denied grant renewals. For some, that means they have to close up shop. The article…

Sorry to get to this so late but I wanted to weigh on an excellent post from my cancer blogging colleague, Orac, the other day on the investigation of CAM therapies in cancer. The post covers a lot of ground, as expected from any of Orac’s exhaustive missives, but I wanted to focus on the…

A paper in last month’s issue of Nature Reviews Drug Discovery reported that US drug approvals during 2007 were the lowest number since 1983. (17 new molecular entities and 2 biologicals; see this figure for 1996-2007 data.) The review cites increased regulatory action as a factor in this reduction, especially following high-profile post-marketing safety issues…

Apologies that I’ve been a bit preoccupied to put up my own content last night and today. In the meantime, I must direct you to an excellent ethics discussion by the always insightful Prof Janet Stemwedel on the research program led by Dr Edythe London, the UCLA researcher who has been terrorized personally by the…

It seems that everyone in the sci/med blogosphere is offering Valentine’s posts reflecting their areas of professional interest. So, here’s mine: Your humble Pharmboy came of age with glam, punk, and New Wave music but thanks to PharmMom, RN, and her then-college-aged ER co-workers, I have a soft spot for 70s soft-rocking singer-songwriters. Yes, Jim…